MiRNA-mediated EMT and CSCs in cancer chemoresistance

Bing Dong(Zhengzhou University), Shiyu Li(Tongji Hospital), Shuangli Zhu(Tongji Hospital), Ming Yi(Tongji Hospital), Suxia Luo(Zhengzhou University), Kongming Wu(Zhengzhou University)
Experimental Hematology and Oncology
February 12, 2021
Cited by 139Open Access
Full Text

Abstract

Cancer stem cells (CSCs) are a small group of cancer cells, which contribute to tumorigenesis and cancer progression. Cancer cells undergoing epithelial-to-mesenchymal transition (EMT) acquire the chemoresistant ability, which is regarded as an important feature of CSCs. Thus, there emerges an opinion that the generation of CSCs is considered to be driven by EMT. In this complex process, microRNAs (miRNAs) are found to play a key role. In order to overcome the drug resistance, inhibiting EMT as well as CSCs phenotype seem feasible. Thereinto, regulating the EMT- or CSCs-associated miRNAs is a crucial approach. Herein, we conduct this review to elaborate on the complicated interplay between EMT and CSCs in cancer chemoresistance, which is modulated by miRNAs. In addition, we elucidate the therapeutic strategy to overcome drug resistance through targeting EMT and CSCs.


Related Papers

No related papers found

Powered by citation graph analysis